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Abstract
THE EFFECT OF A PUFA DIET ON
HUMAN RED BLOOD CELL LEVELS OF 2,3-DPG
by Sandra A. Dassenko
Fasting blood was collected at weekly intervals
and the level of 2,3-DPG of the red blood cell was
determined in 15 male subjects age 28 to 57 with serum
cholesterol levels greater than 250 mg%.

A lacto-

vegetarian diet containing no cholesterol, a high level
of dietary fiber and a P/S ratio of 4.0 was provided for
28 days.
During the course of the experimental period
the 2,3-DPG increased by an average of 0.83>*«moles/ml
red blood cell which was highly significant (p^.001).
This significant increase of 2,3-DPG which relates to
an increased oxygen delivery capability of the red blood
cells would indicate the benefit of this type of diet
to the individual with a high risk of heart disease.
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INTRODUCTION
2,3-diphosphoglycerate was first discovered in pig
erythrocytes in 1925 and later its presence was noted also
in the red cells of humans and in other mammals (Torrance,
1974) .

Over four decades after its discovery, it was found

that 2,3-diphosphoglycerate decreased the oxygen affinity
of hemoglobin and apparently through this mechanism the
oxygen delivery capacity of hemoglobin is regulated (Chanutin
and Curnish, 1967? Benesch and Benesch, 1967).
Erythrocytes are unique in having the highest concentration of 2,3-diphosphoglycerate (2,3-DPG) of any
tissue in the body,

About 76% of the organic phosphate in

the erythrocytes is found as 2,3-DPG while other tissues
have about one-tenth of this amount.

The molar concentration

of 2,3-DPG is about the same as that of hemoglobin found in
the red blood cell.

Other phosphates having similar effects

on the oxygen dissociation characteristics of hemoglobin are
ATP and pyridoxal phosphate which are present in smaller
quantities (White et al., 1973; Torrance, 1974).
Formation of 2,3-DPG
In the Embden-Meyerhof pathway, the RapoportLuebering cycle is a shunt that leads to the production of
2,3-DPG (see figure 1) from the intermediate of glycolysis.
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Figure 1.

Embden-Meyerhof pathway showing RapoportLuebering cycle (Torrance, 1974).

Abbreviations used: HK, hexokinase; G6P, glucose-6-phosphate;
GPI, phosphoglucose isomerase; F6P, fructose-6-phosphate;
PFK, phosphofructokinase; F16DP, fructose-1,6-diphosphate;
DHAP, dihydroxy acetone phosphate; TPI, triosephosphate
isomerase; G3P, glyceraldehyde-3-phosphate; PGD, phosphoglycerate dehydrogenase; 1,3-DPG, 1,3-diphosphoglycerate;
PGK, phosphoglycerate kinase; 3PG, 3-phosphoglycerate; DPG
mutase, diphosphoglycerate mutase; 23 DPG, 2,3-diphosphoglycerate; DPG phosphatase, diphosphoglycerate phosphatase;
Pi, inorganic phosphate; PGM, phosphoglycerate mutase; 2PG
2-phosphoglycerate; PEP, phosphoenol pyruvate; PK, pyruvate
kinase; LDH, lactate dehydrogenase; ATP, ADP, adenosine
triphosphate and adenosine diphosphate; NAD, niacin adenine
dinucleotide.
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1,3-DPG (White et al •

r

1973) .

In the red blood cell about

20% of the glycolytic flux is normally via the formation of
2,3-DPG (Gerlach and Duhm, 1972; Torrance, 1974).

The

enzyme diphosphoglycerate mutase (DPG mutase) is responsible
for the formation of 2,3-DPG from 1,3-DPG while a diphospho
glycerate phosphatase (DPG phosphatase) enzyme catalyzes
the conversion of 2,3-DPG to 3-phosphoglycerate (3-PG).

Of

the two enzymes regulating synthesis and degradation of
2,3-DPG, the DPG mutase is suggested as being more important,
since the DPG phosphatase is less active (Rose, 1970;
Gerlach and Duhm, 1972).
Control of 2,3-DPG Concentrations
The rate of 2,3-DPG synthesis and decomposition
controls the concentration of 2,3-DPG in the red blood cell.
The decomposition of 2,3-DPG is principally influenced by
a decrease in pH which activates the DPG phosphatase to
form 3-PG and inorganic phosphate.

Alternately an increase

in 3-PG concentration inhibits the DPG phosphatase enzyme
activity (Gerlach and Duhm, 1972; Torrance, 1974).
The rate of synthesis of 2,3-DPG is controlled
principally by the 1,3-DPG level (Torrance, 1974).

The

levels of 1,3-DPG are in turn regulated primarily by the
pH and by the inorganic phosphate (Pi) concentration
(Gerlach and Duhm, 1972; Torrance, 1974).

This effect

of pH is mediated through the PFK and PGD enzyme catalyzed
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steps with an increase of pH serving as a stimulus to
these reactions.

Since inorganic phosphate is required

by the PGD enzyme catalyzed reaction the concentration of
Pi available can also control the level of red blood cell
1,3-DPG.

Other factors that control glycolysis such as

NAD/NADH and ATP/ADP ratios also will influence the
quantity of 2,3-DPG produced (Gerlach and Duhm, 1972;
Rapoport et al, 1972).
The rate of synthesis of 2,3-DPG is controlled by
its own concentration also.

2,3-DPG serves as an inhibitor

of DPG mutase (Rose, 1970; Williamson et al, 1970).

As

more oxygen is bound to hemoglobin, more 2,3-DPG becomes
free thus inhibiting the mutase and hemoglobin release of
oxygen to the tissues is altered (Brewer, 1974).

The non-

diffusable anions of 2,3-DPG then shift the hydrogen ions
out of the red blood cell.

A rise of nondiffusable free

2,3-DPG in the red cell decreases the intracellular pH
which decreases the rate of glycolysis, inhibits the mutase
and thereby decreases 2,3-DPG levels (Rouault, 1973;
Gerlach and Duhm, 1972).
Role of 2,3-DPG in Oxygen Binding
The binding of 2,3-DPG to hemoglobin increases the
oxygen availability to the tissues by reducing the oxygen
affinity of the hemoglobin (Klocke, 1972).

Deoxyhemoglobin

binds 2,3-DPG near the center of the molecule through salt
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bridges which are believed to form on the beta chains
between N-terminal amino groups (Arnone, 1974; Torrance,
1974).

Arnone (1974) further suggests the amino acid

residues involved are histidine, lysine, and valine.

After

oxygenation the configuration of hemoglobin changes and the
binding of 2,3-DPG is more difficult (Klocke, 1972).

Benesch

(1967) suggests that 2,3-DPG aids in regulating the allostearic properties of hemoglobin and by this means the
oxygen affinity of the hemoglobin can be controlled.
The level of 2,3-DPG in the cell affects the binding
of oxygen to hemoglobin and the oxygen dissociation curve.
A shift to the right is noted in the oxygen dissociation
curve (ODC) when 2,3-DPG is increased (see figure 2, curve
C).

This shift facilitates the delivery of oxygen to the

tissues (Rouault, 1973; Harkness, 1971).

When 2,3-DPG is

absent or low at a given pC>2 the ODC shifts to the left so
that more oxygen is bound to the hemoglobin but less is
released to the tissues (see figure 2, curve A).

A shift

of the ODC to the left releases less oxygen to the tissues
than when there is a rightward shift (Torrance, 1974).
By altering the affinity of hemoglobin for oxygen,
the level of 2,3-DPG adapts to conditions of hypoxia.

A

change in 2,3-DPG levels was first noted in individuals
when there was an altitude change.

The red blood cells

of people living at high altitudes have higher levels of
2,3-DPG with an observed decrease in oxygen affinity than
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those living at sea level (Eaton et al., 1969; Harper,
1973; White et al •

r

1973) .

Astrup (1970) indicates the

change in 2,3-DPG at high altitudes is caused by a small
change in pH.

Thus there is a fine line balance between

pH and 2,3-DPG.
Although the hypoxic condition was first noted at
high altitude, the occurrence of hypoxia is not limited
to high altitude conditions.

In anemia, pulmonary disease,

impaired cardiac function and other disease states where
oxygen release to the tissues is impaired, a hypoxia
condition exists (Woodson et al., 1970; Brewer and Eaton,
1971).

Decreased oxygen availability to the tissues is

compensated for by an increase in red blood cell glycolysis
and a rise in 2,3-DPG levels which results in a rightward
shift in the oxygen dissociation curve (Woodson et al..
1970; Rouault, 1973; Brewer et al., 1972; Brewer and Eaton,
1971).
Relationship of 2,3-DPG to Hypoxia and Cardiovascular
Disease
Research suggests that the arteriosclerotic changes
noted in rabbits are brought about by hypoxic conditions
(Kjeldsen et al •
1969).

r

1968; Helin et al •

r

1969; Garbarsch et al •

More recent research indicates changes related to

arteriosclerosis contribute to the hypoxic condition
(Chisholm et al •

t

1972; Gainer and Chisholm, 1974) .

In

high cholesterol red blood cell membranes are thicker and

f
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would have greater resistance and be a barrier to oxygen
availability to the tissues with a shift to the left of
the ODC (Steinbach et al •

/

1974).

Papahadjopoulos (1974)

also states even a small increase in concentration of
cholesterol in membranes will affect permeability.
The hypoxia hypothesis linked with increased risk
of coronary artery disease associates elevated serum
cholesterol with preventing the release of oxygen to the
tissues (Brewer, 1972; Brewer, 1974).

The change in

oxygen carrying capacity in coronary artery disease causes
a decreased oxygen availability to the tissues and may
increase the risk of arteriosclerosis (Brewer, 1974; Colvard
and Longmuir, 1973).
Purpose of Study
It has been proposed that arteriosclerosis develops
as a consequence of insufficient transport of oxygen to the
arterial intimal tissues (Gainer and Chisholm, 1974; Brewer,
1974) .

Since 2,3-DPG levels in the red blood cells relate

to the oxygen delivery capability of the red blood cells,
it seemed desirable to determine the effect of a dietary
program which is known to reduce the risk of coronary heart
disease, upon the red blood cell level of 2,3-DPG.

Fifteen

male subjects with cholesterol levels greater than 250 mg%
were given a lacto-vegetarian diet high in polyunsaturated
fats for a period of 28 days with weekly determinations of
2,3-DPG levels.

METHODS
Subjects
Fifteen male subjects were selected from a community
heart attack risk program.

The individuals were selected on

the basis of age, cholesterol level and willingness to
participate in the scientific study.

Age of the men ranged

from 28 to 57 with cholesterol levels 250 mg% and above.
All fifteen individuals participated in the study the entire
28 days.
The men were served three meals a day seven days a
week during the four week research study.

The morning and

evening meals were served in the Nutrition Research Kitchen.
After breakfast each morning the subjects were given a
prepared sack lunch for the noon meal.
A research laboratory in the Nutrition Department
was arranged to collect blood samples by a medical technologist and a physician,

Each Sunday morning between

seven and eight am* the subjects had a fasting blood sample
drawn.

Breakfast was served immediately after the blood

drawing.
Diet
The individuals were provided a lacto-vegetarian
diet during the 28 day study.

Polyunsaturated/saturated
9
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fat ratio, cholesterol level and fiber content were
specifically altered in the diet,

Less than 35% of the

daily caloric intake was fat with the polyunsaturated/
saturated (P/S) fat ratio of 4.0.

The main sources of

fat included a polyunsaturated corn oil margarine, liquid
corn oil and vegetarian meat analogs.

No significant

source of cholesterol in foods was provided and an egg
substitute was used for breakfast and baking.
Fiber was included in the diet at 10 grams per
day.

Foods high in fiber such as fresh fruit and vegetables.

whole grain breads and cereals and textured vegetable
protein (TVP) were used.

An additional amount of fiber

was added in the form of bran to cereal or entree or dessert to increase the amount of fiber on some days.

(See

appendix for approximate composition of daily menu.)
The menu for the 28 days was a 7 day cycle (See
appendix).

The first week began with day one menu and

subsequent weeks with day two menu, day three menu and day
four menu.
week.

No meal was the same for any given day each

Once a week a buffet supper with a specific cultural

theme was served.
The individuals were not restricted on total food
intake except for desserts, maintaining weight (not gaining
or losing more than five pounds during the study).

The

individuals ate all the meals from the food provided.
was not limited.
study.

Water

No alcohol was to be consumed during the
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Each day's diet was adequate in the RDA of nutrients
and no supplementation was given.

A computerized nutrient

analysis was computed from USDA Handbook #8.
DPG Determination
The procedure for determining 2,3-DPG in the
erythrocyte followed instructions in a kit by CalBiochem,
La Jolla, California (see appendix).

The kit was developed

based on the method of Nygaard and Rorth (1969).

The test

kit worked with "2,3-DPG as an essential rate determining
co-factor in the conversion of 3-PG to 2-PG catalyzed by
PGM.

The 2-PG formed is subsequently converted into PEP

by enolase.

PEP reacts with ADP in the presence of PK to

yield pyruvate and ATP.

The pyruvate is then reduced to

lactate by LDH; simultaneously, a molar equivalent quantity
of NADH is oxidized.

The rate of change in absorbance at

340 nm is proportional to the concentration of 2,3-DPG in
the sample".
Fasting blood was collected in tubes containing
anticoagulant EDTA.

After mixing the blood specimen and

anticoagulant by inversion the specimen was placed in an
ice-water bath.

Immediately the capillary pack cell

volume was determined by hematocrit.

A 0.1 ml sample of

blood was diluted with 9.9 ml of distilled water and mixed
well.

The diluted sample was then placed in an iced water

bath for five minutes for hemolysis to occur.

The
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hemolysate was then frozen and stored with the analysis
being made within three days after collection,

(Recommended

time limit for storage of hemolysate in the frozen state is
one week.)
The reagent from the kit was reconstituted, refrig
erated and used within the six hour limit for the storage
time.

A hemolysate sample was removed from the freezer

and allowed to thaw until only a small amount of ice
remained then placed in a 30° C. water bath to warm.

A

pipette was used to dispense 3.0 ml of reagent into a
clean, dry test tube.

The reagent was then placed in the

constant-temperature waterbath to bring the reagent to
the required temperature.
reached 30° C •

>

After the sample and reagent

0.1 ml of sample was added to the reagent.

This was mixed thoroughly by inversion then approximately
3.0 ml of sample-reagent mixture was transferred imme
diately to a clean dry cuvet which had also been in the
constant-temperature waterbath.

After drying the cuvet,

it was promptly placed into the temperature controlled
cell compartment of the photometer.

An initial absorbance

was read approximately two minutes after placing the cuvet
in the instrument.

A timer was simultaneously started

and exactly four minutes after the initial reading the
final absorbance was read.

Using water as a blank all

measurements were made in the photometer at 340 nm and
30° C.
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The change in absorbance was obtained by sub
tracting the final absorbance from the initial value,

The

moles of 2,3-DPG/ml red blood cells was then calculated
using the formula
100
A(4 minutes) x N x PCV x D
where
A A = change in absorbance in 4 minutes
2.5
N = a conversion factor AA (for 4 minutes)
where 2.5 = equivalent concentration of
standard in undiluted whole blood
PCV = value of the hematocrit in percent of
packed red blood cells
D = dilution factor which was 1 as 100
microliters of sample was used

RESULTS AND DISCUSSION
A lacto-vegetarian diet which was high in poly
unsaturated fat (P/S ration 4.0) and high in dietary fiber
(10 grams fiber/day) was fed to 15 male subjects who had
serum cholesterol levels greater than 250 mg% for a period
of 28 days.

Weekly blood samples were drawn and the 2,3-DPG

was determined.

A significant rise in levels of 2,3-DPG

was noted (p ^.001) between an initial blood sample and
after 28 days on a lacto-vegetarian diet (see figure 3).
The average rise in 2,3-DPG levels during the study was
0.83 yM.moles/ml red blood cell with an initial average
reading of 4.45 ^moles/ml red blood cells to a final
reading of 5.28 ^moles/ml red blood cells.
(1974) and Bunn et al.

Arturson et al.

(1974) suggest levels from 4.67 to

5.0 >umoles/ml red blood cells.

During the same time

period a significant decrease in cholesterol levels was
observed (p^.001)

(see figure 4).

The average decrease

in cholesterol during the time was 78 mg%.
reported elsewhere (Johnson, 1975) .

Complete data

The 2,3-DPG and

cholesterol data were analyzed using computer program
BMDX64 (Dixon, 1969) having 2,3-DPG as the dependent
variable with week and Cholesterol as covariables.
Cholesterol was also analyzed as the dependent variable
with week and 2,3-DPG as covariables.
14

These analyses
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suggest that the relationship between 2,3-DPG and choles
terol is not causal but the changes in both are related to
time 01^ the diet,

The dietary fat and fiber content were

the only changes in life style that the subjects experienced.
For this reason these dietary changes are regarded as the
cause for the observed changes in 2,3-DPG.
A change in dietary lipids affect the type of
lipids found in the plasma which are in a dynamic equilib
rium with lipids in the erythrocyte membrane (Tarlov, 1966;
London and Schwarz, 1953; Reed, 1968).

A change in type

and level of plasma lipids would then change the erythrocyte
membrane lipids.

In 1968 and again in 1970, De Gier found

the permeability of liposome membranes was influenced by
the fatty acid composition.

The liposome membrane was

also shown to be affected by cholesterol which reduced
permeability (Demel et al., 1968; De Gier et al., 1969).
Papahadjopoulos (1974) suggests the level of cholesterol
in membranes controls the fluidity and structure with a
more stable structure decreasing permeability and electrical
conductivity.

Increased amounts of cholesterol contribute

to a more stable structure and can inhibit membrane enzymes
and reduce the transport rate of ions.

The prediction is

that a small increase in membrane cholesterol may greatly
effect permeability.
Steinbach et al.

This hypothesis is supported by

(1974) whose data showed that high blood

cholesterol levels lowered red blood cell oxygen saturation
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in rabbits, which was interpreted as relating to a reduction
of oxygen transport across the red cell membrane.

These

reported changes in membrane transport may explain the in
crease in red blood cell 2,3-DPG in response to changes
in dietary lipids.

Thus the observations in this study

may relate to a change in glucose transport across the
red blood cell membrane.
Additional studies relating to the activity of the
DPG mutase and DPG phosphatase enzymes may also account
for the change in levels of 2,3-DPG.

A change in pH may

be suggested for further study because as pH changes, the
rate of glycolysis, the activity of the enzymes and level
of 2,3-DPG is altered.
In subjects with a high risk of heart disease,
the increased availability of oxygen for the tissues
possibly brought about by an increase in the level of
2,3-DPG would be beneficial.

SUMMARY
Fifteen men ages 28 to 57 with a serum cholesterol
greater than 250 mg% were given a lacto-vegetarian diet
for 28 days.

The diet had a P/S ratio of 4.0, no choles

terol containing foods and included a high level of fiber.
The blood (fasting) was collected at weekly inter
vals and the 2,3-DPG level of the red blood cell was
determined.

During the course of the experimental period

the 2,3-DPG increased with time,

At the end of the experi-

mental period, 2,3-DPG had increased by an average of 0.83
^mole/ml of red blood cell which was highly significant
(p<.001).

This significant increase of 2,3-DPG which

relates to an increased oxygen delivery capability of the
red blood cells would indicate the benefit of this type
of diet to the individual with a high risk of heart disease.

19

BIBLIOGRAPHY

BIBLIOGRAPHY
Arnone, Arthur. 1974. Mechanism of action of hemoglobin.
Annual Review of Medicine. 25:123-130.
Arturson, G., L. Garby, M. Rober and B. Zaar. 1974. Oxygen
affinity of whole blood in vivo and under standard
conditions in subjects with diabetes mellitus. The
Scandinavian Journal of Clinical and Laboratory
Investigation.
34(l):19-22.
Astrup, P. 1970. Red Cell Metabolism and Function, ed.'
George J. Brewer. Advances in Experimental Medicine
and Biology. 6:67-79. New York: Plenum
Benesch, Reinhold and Ruth E. Benesch. 1967. The effect of
organic phosphates from the human erythrocyte on the
allostearic properties of hemoglobin. Biochemical
and Biophysical Research Communications. 26(3):
162-167.
Brewer, George J. 1972. Alfred Benzon Symposium, Oxygen
Affinity of Hemoglobin and Red Cell Acid Base Status,
eds. M. Rorth and P. Astrup. IV:629-645.. New York:
Academic. 832 p.
1974.
2,3-DPG and erythrocyte oxygen affinity.
Annual Review of Medicine.
25:29-38.
Brewer, George J. and John W. Eaton, 1971. Erythrocyte
metabolism: interaction with oxygen transport.
Science. 171:1205-1211.
Brewer, George J • r Fred J. Oelshlegel, Jr., and John W.
Eaton. 1972. Alfred Benzon Symposium, Oxygen
Affinity of Hemoglobin and Red Cell Acid Base
Status, eds. M. Rorth and P. Astrup, IV:539-551.
New York: Academic. 832 p.
Bunn, H. Franklin, Ulysses S. Seal, and Alan F. Scott.
1974. The role of 2,3-diphosphoglycerate in
mediating hemoglobin function of mammalian red cells.
Annals New York Academy of Sciences. 241:498-512.
Chanutin, A. and R. Curnish. 1967. Effect of organic and
inorganic phosphates on the oxygen equilibrium of
human erythrocytes. Arch Biochem Biophysics.
121:96-102.
21

22
Chisholm, G. M., John L. Gainer, G. E. Stoner and James V.
Gainer, Jr.
1972. Plasma proteins, oxygen transport and atherosclerosis. Atherosclerosis. 15:
327-343.
Colvard, M. Clark and I. S. Longmuir. 1973. The effects
of pacing on oxygen hemoglobin dissociation and
oxygen carrying capacity in patients suspected of
coronary artery disease. American Heart Journal.
85(5):662-664.
De Gier, J., C. Wm. Haest, J. G. Mandersloot and L. L. M.
Van Deenan. 1970. Valinomycin-induced permeation
of 86Rb+ of liposomes with varying composition
through the bilayers. Biochim Biophys Acta.
211:373-375.
De Gier, J • r J. G. Mandersloot and L. L. M. Van Deenan.
1968. Lipid composition and permeability of
liposomes. Biochim Biophys Acta. 150:666.
. 1969. The role of cholesterol in lipids membranes. Biochim Biophys Acta. 173:143-145.
Demel, R. A • r S. C. Kinsky, C. B. Kinsky and L. L. M.
Van Deenan. 1968. Effects of temperature and
cholesterol on the glucose permeability of lipo
somes prepared with natural and synthetic lecithins.
Biochim Biophys Acta. 150:655-665.
Dixon, W. J. ed.
1969. BMD Biomedical Computer Programs.
University of California Press. Los Angeles,
California.
Eaton, John W • / George
1969. Role of
the adaptation
Laboratory and

J. Brewer, and Robert F. Grover.
red cell 2,3-diphosphoglycerate in
of man to altitude. The Journal of
Clinical Medicine. 73(4):603-609.

Gainer, J. L. and G. M. Chisholm, III. 1974. Oxygen dif
fusion and atherosclerosis. Atherosclerosis.
19 (1):135-138.
Garbarsch, C., M. E. Matthiessen, P. Helin, and I.
Lorenzen. 1969. Arteriosclerosis and hypoxia.
Journal of Atherosclerosis Research. 9:283-294.
Gerlach, E. and J. Duhm.
1972. Alfred Benzon Symposium,
Oxygen Affinity of Hemoglobin and Red Cell Acid
Base Status. eds. M. Rorth and P. Astrup. IV:
832 p.
552-569. New York: Academic.

23
Harkness, D. R.
1971. The regulation of hemoglobin
oxygenation. Advances in Internal Medicine.
17:189-214.
Harper, Harold A.
1973. Review of Physiological Chemistry.
14th ed. Lange Medical Publications. Los Altos,
California.
Helin, P • / and I. B. Lorenzen. 1969. Arteriosclerosis in
rabbit aorta induced by systemic hypoxia. Angiology.
20 (1) :1-12.
Johnson, Linda.

1975.

Masters thesis in preparation.

Kjeldsen, K., J. Wanstrup, and P. Astrup. 1968. Influence
of arterial hypoxia on atheromatosis. Journal of
Atherosclerosis Research.
8:835-845.
Klocke, Robert A. 1972.
glycerate (DPG).

Oxygen transport and 2,3-diphospho62(5):Supplement:795-855.
Chest.

London, I. M. and H. Schwarz. 1953. Erythrocyte metabolism.
The metabolism behavior of the cholesterol of human
erythrocytes. Journal of Clinical Investigation.
32:1248-1252.
Nygaard, S. F., and M. Rorth. 1969. An enzymatic assay of
2,3-diphosphoglycerate in blood. The Scandinavian
Journal of Clinical and Laboratory Investigation.
24 (4) :399-403.
Papahadjopoulos, Demetrios. 1974. Cholesterol and cell
membrane function: A hypothesis concerning the
etiology of atherosclerosis. Journal of Theoretical
Biology.
43:329-337.
Reed, Claude F. 1968. Phospholipid exchange between plasma
and erythrocytes in man and the dog. Journal of
Clinical Investigation. 47:749-760.
Rapoport, S., D. Maretzki, Ch. Schewe and G. Jacobash.
1972. Alfred Benzon Symposium, Oxygen Affinity of
Hemoglobin and Red Cell Acid Base Status. eds.
M. Rorth and P. Astrup. IV:527-538. New York:
832 p.
Academic.
1970. Red Cell Metabolism and Function.
Rose, Zelda B.
ed. George J. Brewer. Advances in Experimental
Medicine and Biology. 6:137-153. New York: Plenum.

24
Rouault, Charles. 1973. Red cell oxygen delivery: Effect
of 2,3-diphosphoglycerate. Postgraduate Medicine.
53(3):201-203.
Steinbach, Joseph H., P. L. Blackshear, R. L. Varco, and H.
1974. High blood cholesterol reduces
Buchwald.
in vitro blood oxygen delivery. Journal of
16:134-139.
Surgical Research.
Tarlov, Alvin R. 1966. Lecithin and lysolecithin metabolism
in rat erythrocyte membrane. Blood. 18:990-991.
Torrance, J. D. 1974. Clinical implications of the inter
action between 2,3-diphosphoglycerate and hemoglobin.
South African Journal of Medical Sciences. 39(1):
33-61.
White, A., P. Handler and E. L. Smith. 1973. Principles of
5th ed. McGraw-Hill, New York.
Biochemistry.
Williamson, John R. 1970. Red Cell Metabolism and Function,
ed. George J. Brewer. Advances in Experimental
Medicine and Biology.
6:117-136. New York:
Plenum.
Woodson, R. D., J. D. Torrance, S. D. Shappell and C.
Lenfant. 1970. The effect of cardiac disease on
hemoglobin-oxygen binding. Journal of Clinical
Investigation. 49:1349.

>

%

APPENDICES

26
Table 1
AVERAGE COMPOSITION OF A DAILY MENU

Average calories

2500

Percent of calories from fat

35%

Percent of calories from protein

14%

Percent of calories from carbohydrate

51%

Average grams of fiber

10 grams

Mg. cholesterol

insignificant
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Table 2
A SEVEN-DAY LACTO-VEGETARIAN MENU
FOR CHOLESTEROL LOWERING STUDY
DAY 1

DAY 2

Breakfast
Grapefruit half
Meat analog
Whole grain cereal, cooked
Cracked wheat toast

Breakfast
Banana
Granola
Meat analog
Cracked wheat toast

Noon
Sandwich
Whole Wheat bread
Meat analog
Lettuce, tomato
Salad dressing
Cucumber slices
Fresh pear
Applesauce cupcake

Noon
Chicken-style salad
Cornbread muffin/margarine
Fresh orange
Cranberry crisp

Evening
Cashew Nut Loaf
Mashed potatoes/gravy
Carrots
Tossed salad/Fr. or It.
Dressing
Fruit jello

Evening
Meat analog
Baked potato/margarine
Mixed vegetables
Tossed salad/Fr. or It.
Dressing
Fresh fruit plate

DAY 3

DAY 4

Breakfast
Orange juice
Scrambled Egg substitute
Meat analog
Cracked wheat toast

Breakfast
Banana
Oatmeal/raisins
Meat analog
Bran muffin

Noon
Sandwich
Whole Wheat bread
Loma Linda sandwich spread
Lettuce
Salad dressing
Fresh pear
Chip oatmeal cookies

Noon
Sandwich
Whole Wheat bread
Meat analog
Lettuce
Salad dressing
Cucumber slices
Apple pie cake
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Evening
Stroganoff/brown rice
Broccoli
Tossed salad/Fr. or It.
Dressing
Jello parfait

Evening
Tamale Pie
Baked potato/margarine
Green beans
Coleslaw
Fresh orange segments

DAY 5

DAY 6

Breakfast
Apple wheat waffles
Peanut butter
Applesauce
Meat analog

Breakfast
Grapefruit half
Brown rice/raisins
Meat analog
Cracked wheat toast

Noon
Macaroni salad
Rye krisp
Fresh apple
Fruit bars

Noon
Sandwich
Hard roll
Meat analog
Lettuce, tomato
Carrot sticks
Fresh pear
Gingersnap cookies

Evening
Spaghetti/meatballs & sauce
Garlic toast
Peas
Tossed salad/Fr. or It.
Dressing
Fruit sherbet

Evening
SPECIAL MENU
Chili dogs
Chinese supper
Burgers

DAY 7
Breakfast
Fruit over toast
Scrambled Egg substitute
Meat analog
Lunch
Sandwich
Meat analog
Lettuce, tomato
Whole Wheat bread
Salad dressing
Green pepper
Banana
Peanut butter cookies

f
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Evening
Tacos
Beans
Lettuce, tomato
Low fat cheese
Fresh fruit

Each day's menu also
included
Orange juice for breakfast
Non fat milk
Corn oil margarine
Whole Wheat bread

r
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Table 3
EFFECT OF DIET ON LEVEL OF 2,3-DPG IN MOLES/ML
RED BLOOD CELLS IN EACH OF 15 SUBJECTS
Weeks on Diet
Subjects

0

1

2

3

4

C.B.

4.25

4.60

5.23

4.31

5.22

A. C.

4.33

4.27

4.12

5.24

4.71

W.C.

4.76

3.80

7.24

5.48

6.61

R.G.

3.63

4.21

5.17

4.52

4.69

W.G.

4.04

3.19

3.62

3.65

5.58

H.J.

3.31

3.18

4.27

4.35

4.10

H.J.

4.94

4.18

5.39

5.49

5.76

B.L.

4.56

4.26

4.44

5.02

5.84

H.R.

4.56

5.22

4.49

5.74

4.69

O.S.

4.46

4.14

5.92

4.57

5.03

V.S.

4.37

5.48

5.94

4.59

5.75

F.S.

4.08

4.83

6.36

4.11

5.20

I.S.

4.36

4.35

4.03

2.70

5.22

P.S.

4.90

3.11

4.15

6.21

5.13

J.T.

6.15

3.95

4.48

4.50

5.71

Mean

4.45

4.33

4.99

4.70

5.28

Standard Error

0.17

0.23

0.26

0.23

0.16
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Calbiochem reagents for the quantitative measurement of 2,3-diphosphoglycerate (2,3-DPG) in
erythrocytes are of high quality. Each reagent is prepared from components of specified purity which
have met Calbiochem's stringent quality control standards. They are formulated in accordance with
current good manufacturing practices.
Calbiochem's 2,3-DPG reagents are based on the method of Nygaard and Rorth (1). The concen
trations of the reactants have been changed in the optimization of the reagent. This optimization has
resulted in a lower level of 3-phosphoglyceric acid, LDH, enolase anc phosphoglyceromutase in the
reagent, and a reduction in the blank rate. A rate assay was selected over the stoichiometric procedure
described by Rose and Liebowitz (2) as the rate assay is virtually specific, has a low blank, eliminates
preparation of a protein-free filtrate, requires less sample and shorter working time. The method re
quires the assay of a standard and the use of a photometer capable of measuring absorbance changes
at 340 nm.
Among the most important physiological properties of hemoglobin (Hb) is being an oxygen carrier
in erythrocytes. Hemoglobin's ability to release oxygen into the environmental tissues during the lim
ited time the erythrocytes are in the tissue capillaries may be evaluated by 2,3-DPG assays.
A knowledge of the effect the erythrocytes' enzymatic constituents have on this property is of vital
importance (3, 4, 5, 6).
Normal erythrocytes of humans and other mammals contain 2,3-DPG in a molar concentration
comparable to hemoglobin. It has been recently shown that 2,3-DPG can be bound on an equimolar
basis with deoxyhemoglobin (7). In the resulting complex, the affinity of hemoglobin for oxygen is
lower than hemoglobin in a salt-free solution. As a result, in the presence of a sufficient amount of
2,3-DPG, the release of oxygen by hemoglobin to the tissue is facilitated. However, stored blood, in
which the level of 2,3-DPG has decreased below a critical point, has a high oxygen affinity and is thus
unable to release oxygen to the tissues. This blood is of little benefit to the critically ill patient.
2.3-Diphosphoglycerate is the phosphate compound present in largest concentration (3.5 /iM/ml)
in the normal human erythrocytes, where it contributes approximately one-third of the total organic
phosphorus. The disappearance of this metabolite during blood bank storage is the first and most sig
nificant index of a decline in the viability of erythrocytes.
Erythrocytes depleted of 2,3-DPG during storage will, following transfusion regenerate significant
amounts of the metabolites, but only after a clinically significant time. This regeneration will occur in
the same cells after a relatively short period of incubation with ribonucleosides. Similarly, in cells
stored in ACD solution containing inosine, the level of 2,3-DPG is maintained for a longer period than
in ACD alone (4,8, 7).
2.3-DPG acts as a readily available store against which the cell can draw to satisfy critical metabol
ic requirements. The concentration of 2,3-DPG increases in response to decreased environmental oxy
gen tension. Thus, in individuals moving from a low to a high altitude, the level of 2,3-DPG rises.
After strenuous muscular exercise and in conditions associated with hypoxia, e.g., obstructive pul
monary emphysema, chronic pulmonary disease, right to left cardiac shunt, severe anemia and thyro
toxicosis, etc., the level of 2,3-DPG is increased (8, 9, 10). Patients with erythrocytes deficient in
pyruvate kinase are also reported to have increased levels of 2,3-DPG (11).

TEST PRINCIPLE
3-PG

2,3 PPG
► 2-PG
PGM

2-PG

Enolase
► PEP

PEP + ADP

PK

Pyruvate + NADH

Pyruvate + ATP
LDH

Lactate + NAD

Abbreviations:
ADP
ATP
2,3-DPG
LDH
NAD
NADH
PEP
2-PG
3-PG
PGM
PK

Adenosine-5 d iphosphate
Adenosine-5-triphosphate
2,3-diphosphoglycerate
Lactate dehydrogenase
Nicotinamide-adenine dinucleotide
Nicotinamide-adenine dinucleotide, reduced
Phosphoenol pyruvate
2-phosphoglycerate
3-phosphoglycerate
Phosphoglycerate mutase
Pyruvate kinase

In this reaction, 2,3-DPG is an essential rate determining co-factor in the conversion of 3-PG to
2-PG catalyzed by PGM. The 2-PG formed is subsequently converted into PEP by enolase. PEP reacts
with ADP in the presence of PK to yield pyruvate and ATP. The pyruvate is then reduced to lactate
by LDH; simultaneously, a molar equivalent quantity of NADH is oxidized. The rate of change in
absorbance at 340 nm is proportional to the concentration of 2,3-DPG in the sample.

REAGENT COMPOSITION

PRECAUTIONS
If
Vial contents may be under vacuum,
there is any indication moisture has penetrated
the seal, discard the vial in question.
For In Vitro Diagnostic Use

"A" vials (reagent), when reconstituted ac
cording to instructions, will yield a solution
containing approximately
Tris buffer
0.1 moles/liter
3-Phosphoglycerate 1.9 x 10-3 moles/liter
Adenine
8.7 x 10~3 moles/liter
diphosphate
Lactate
dehydrogenase
2000 I U/liter
2000 I U/liter
Pyruvate kinase
Enolase
167 I U/liter
Phosphoglycerate
mutase
100 I U/liter
Non-reactive
stabilizer
pH 7.5
"B" vials (cofactor), when reconstituted ac
cording to instructions, will yield approximately
NADH
1.9 x 10_^moles/liter
Non-reactive
stabilizer
“2,3-0 iphosphoglycerateStandard” contains
2,3-DPG
250 /imoles/dl

RECONSTITUTION OF THE
REAGENTS
A. Stat-Pack™ (Cat. No. 869237)
1. Reconstitute the contents of one of the
B vials (cofactor) with 15.5 ml of dis
tilled water. Cap and invert genf/y.
2. Open one of the A vials and transfer the
entire contents of the B vial into it. Cap
and invert gently.

STORAGE AND STABILITY
Unopened vials are stable for at least 12
months when stored between 2° and 8°C. The
reconstituted and combined reagent A and B is
stable for at least 6 hours when stored in a glass
container between 2° and 8°C.
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If evidence of bacterial contamination ap
pears, discard the solution.
If the well-mixed reagent shows an initial ab
sorbance measured against distilled water of less
than 0.7 at 340 nm, consider the reagent un
suitable for 2,3-DPG assay and discard.

Dilute 1 volume of cells with 199 volumes
of distilled water (1:200 dilution). Mix well
by inversion and store frozen until use. De
termine the hematocrit of the packed cells
for use in the calculations.
2. An alternative procedure is to centrifuge the
sample in a calibrated capillary tube using a
microhematocrit centrifuge. After reading
the hematocrit, the capillary tube can be cut
at the interface between white cells and red
cells. Dilute 1 volume of packed cells with
199 volumes of distilled water (1:200 dilu
tion) . M ix well by inversion and store frozen
until use.

SPECIMEN COLLECTION AND PREPA
RATION FOR ANALYSIS
Preparation of the Hemolysate
1. The blood may be collected in most of the
commonly employed anticoagulants: EDTA,
heparin, oxalates and ACD (acid-citratedextrose) can be used. Blood collected in
fluorides (e.g. Vacutainer® grey-stoppered
tubes) cannot be used in this assay. Blood
collected in ACD solution may be stored at
4°C.
Since the 2,3-DPG levels in blood
change rapidly after collection, prepare the
hemolysate without undue delay.
2. Mix the blood specimen and anticoagulant
by inversion. Determine the hematocrit by
any accurate technique for use in the calcu
lations. Dilute 0.1 ml of blood with 9.9 ml
of distilled water (1:100 dilution) and mix
well. As most 2,3-DPG is found in the eryth
rocytes, a 1:100 dilution virtually eliminates
the possibility of interfering contaminants
owing to their extremely low concentrations
in the diluted sample.
3. Place the diluted specimen in an iced waterbath for 5 minutes.
4. Store hemolysate frozen until assayed. Hemolysates of whole blood or packed red
cells can be stored frozen for at least a week
without loss of 2,3-DPG. If samples are to
be stored for a longer period, prepare a per
chloric acid protein-free filtrate. Dilute 1
volume of well-mixed blood with 4 volumes
of 0.6 M perchloric acid (5.15 ml of 70%
perchloric acid diluted to 100 ml with dis
tilled water). Mix well. Let stand for 5 min
utes; centrifuge for 5 minutes at 3000 RPM.
Dilute 1 volume of the supernatant with 19
volumes of distilled water. Final dilution is
1:100.

INTERFERING SUBSTANCES
To test the sample for interfering substances,
assay the sample and a standard separately and
then combined. If no interfering substances are
present, the total 2,3-DPG assayed in the mix
ture will equal the sum of the sample plus the
standard.
Fluoride at concentrations used in blood col
lecting tubes will interfere with this assay.

PREPARATION OF THE PATIENT
No special
required.

preparation of the patient is

PROCEDURE
Reagents Supplied
Vial A — 2,3-DPG Reagent (buffer, enzyme,
substrate)
Vial B — NADH (cofactor)
2,3-DPG Standard
Reagents Not Supplied
ACD — made up as follows:
1.32 gm
Trisodium citrate (dihydrate)
0.48 gm
Citric acid (monohydrate)
1.47 gm
Dextrose (monohydrate)
Dissolve and bring to a final volume of 100 ml.
Use 1.2 ml of this solution for 5 ml of blood.
Material Required But Not Provided
1. A photometer capable of reading absorbance
changes at 340 nm.
2. Constant-temperature waterbath or device
for controlling temperature at 30°C.
3. Suitable matched cuvets with a known light
path.

Alternate Procedure
Hemolysates can also be prepared from
packed red cells by one of the following
procedures:
1. Cool blood in an iced waterbath. Centri
fuge for at least 15 minutes at 3000 RPM.
Withdraw the plasma, leukocytes and the
top part of the red cells. Mix the cells well.

4. Class A volumetric pipets, or similarly accu
rate dispensing devices, for measuring the vol
umes or multiplesof the volumes required by
the assay.
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5. M icropipets, or similarly accurate devices, ca
pable of delivering 0.100 ml (100 jlil) or less.
The accuracy should be 0.008 ml/ml.
6. Timer
7. To prepare reagent solutions use only highly
purified distilled or deionized water, free of
particulate and microbial contamination, at
ambient temperatures.
8. Parafilm®

STANDARDIZATION
A standard solution containing 2.5 jdmoles
of 2,3-DPG per ml of solution (250/Xmoles/dl)
is supplied with every package. This solution
can be used to standardize the procedure in the
laboratory. Calbiochem recommends that a de
termination of the factor "N" be included in
each batch of test specimens run. In addition, a
complete calibration curve should be deter
mined at periodic intervals to insure linearity
of response over the entire range of the test
with the instrument used.
1. Determination of Factor N: Dilute 1 vol
ume of the standard with 99 volumes of dis
tilled water. This gives a solution containing
25 nanomoles of 2,3-DPG per ml of solution
(equivalent to the concentration of 2,3-DPG
in a 1:100 dilution of whole blood contain
ing 2.5 jUmoles 2.3-DPG/ml).
Assay the
diluted standard following steps 1-6 under
"Assay". Calculate the factor "N" from the
formula:
2.5
N =
Aa (for 4 minutes)
where N = calibration factor, 2.5 = equiva
lent concentration of standard in undiluted
whole blood, and Aa (for 4 minutes) = the
absorbance change observed for the diluted
standard solution.
2. Calibration Curve. To construct a calibra
tion curve corresponding to the original val
ues for whole blood before dilution, dilute
the standard as follows:
Original

TEMPERATURE FACTORS
The absorbance change of the sample and
of the standard must be measured at the same
temperature.
At temperatures below 22°C, the reaction
rate may be too slow while above 37°C, the
enzymes may be inactivated.
Use 30°C, if
possible.

ASSAY
Depending on the technical equipment avail
able, specimen/assay volume ratios may vary.
1. Using a suitable pipet, dispense 3.0 ml of the
prepared reagent into a clean, dry cuvet.
2. Using water as a blank, make all measure
ments at 340 nm.
3. Place the cuvets in a constant-temperature
waterbath for 3 minutes or as long as needed
to bring the reagent to the established tem
perature. Preincubate the sample for the
same length of time in the same bath. Cal
biochem recommends this test be performed
at 30°C.
4. Add 0.100 ml (100 microliters) of sample to
the cuvet. Mix quickly by gentle inversion
with a square of Parafilm® over the mouth
of the cuvet. Avoid shaking as this can trap
air bubbles in the solution. Wipe the cuvet
dry and immediately insert into the tempera
ture controlled cell compartment of the pho
tometer. A constant temperature must be
maintained while obtaining assay values.
5. Read the initial absorbance (Aq) approxi
mately 2 minutes after placing the cuvet in
the instrument.
Simultaneously, start a
timer.
6. Exactly 4 minutes after the initial reading,
determine the final absorbance (A4).
7. If the absorbance change of a sample is more
than twice that observed for the standard, re
peat the test using less sample. Use dilution
factor D (see ifel under 'Calculation') to com
pensate for the dilution.

Standard

Water

Blood
Value

1 volume + 249 volumes = 1 /tmol/ml
1 volume + 99 volumes = 2.5 /imol/ml
1 volume + 49 volumes = 5^mol/ml
Assay the diluted standards according to the
test procedure. Plot on graph paper the con
centration of the standard versus the cor
responding Aa for 4 minutes. This curve
may not pass through the origin.

QUALITY CONTROL
Hemolysates of whole blood, packed red
blood cells (both of which can be stored frozen
for one week) or a perchloric acid, protein-free
filtrate (which can be stored frozen for periods
longer than one week) should be analyzed daily
along with the samples. To prepare the proteinfree filtrate, dilute 1 volume of well-mixed blood
with 4 volumes of 0.6M perchloric acid (5.15 ml
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using 100 microliters of sample (D = 1), N =
9.7, hematocrit = 41% and with 1:100 hemolysate dilution:
Aa (for 4 minutes) = 0.770 - 0.510 = 0.260
Then:

of 70% perchloric acid diluted to 100 ml with
distilled water). Mix well. Let stand for 5 min
utes; centrifuge for 5 minutes at 3000 RPM.
Dilute 1 volume of the supernatant with 19 vol
umes of distilled water to obtain a final dilution
of 1:100.
Daily quality control should fall within 2
standard deviations of the established value. If
the precision of the assay system does not cor
relate with this standard and repetition excludes
errors in technique, check the following areas:
1. Cleanliness of glassware, especially cuvets.
2. Purity of water (deionization is good if water
has a conductivity of 1 jUMHOS or less).
3. Instrument wavelength setting, light source
and absorbance calibration.
4. Reaction temperature, including temperature
control systems.
5. Pipetting and timing mechanisms.
6. Expiration date of the reagent package and
the reconstituted reagents.
7. Storage conditions of reconstituted reagents.

0.260 x9.7

Aa (for 4 minutes) x N x 2 x

^ x D -

/Imole 2,3-DPG/ml red blood cells.
Calculation for Alternate Procedure $2
Aa (for 4 minutes) x N x 2 x D = /Jmole
2,3-DPG/ml red blood cells.

LIMITATIONS
When determining values in highly active
specimens, altering the assay volumes may be
necessary. Departures from the recommended
specimen/assay volume ratio will necessitate
changes in the calculation factor.

CALCULATION
For a 1:100 dilution of whole blood, the 2,3DPG concentration in /Umoles per ml of red
blood cells = Aa (for 4 minutes) x N x

6.15 ,Umoles 2,3-DPG/ml

red blood cells.
Calculation for Alternate Procedure #1

EXPECTED VALUES
Calbiochem recommends each laboratory es
tablish its own recovery values suitably repre
sentative of the "normal" range for the assay.
The range of expected values determined for
2,3-DPG in apparently healthy human specimens
is reported to be from 3 to 4.4 /Umole/ml red
blood cells (1).

x D.

Aa is the observed change in absorbance in the
4-minute period. N is the conversion factor, de
termined empirically for each reconstituted re
agent as stated in "Standardization,” PC V is the
value of the hematocrit in percent of packed red
blood cells and D is a dilution factor.
1. To obtain Aa, the change in absorbance,
subtract the final absorbance (A4) from the
initial absorbance (A0):
Aa (for 4 minutes) = A0 - A4.
2. If the reaction is too fast or too slow, use re
spectively more or less sample. The actual
amount of sample used determines the dilu
tion factor D as follows:
D = 1, when 100 microliters of sample are
used.
D = 1.97, when 50 microliters of sample are
used.
D = 0.52, when 200 microliters of sample
are used.
If D is other than 1, multiply the answer by
this dilution factor.
3. Calculation example (in/tmoles 2,3-DPG/ml
red blood cells):
When A0 = 0.770 and A4 = 0.510 at 30°C

PERFORMANCE
Assuming the minimum absorbance change
which can be measured is 0.004 in 4 minutes (N
equals 9.7 and the hematocrit is 41%), the sen
sitivity of the method would be 0.09 /imoles of
2,3-DPG/ml red blood cells.
It has been found that the diluted sample
does not contain substances at concentrations
high enough to interfere with the assay (7).
Since the assay is sensitive to slight variations in
some of the reaction parameters, it is necessary
to standardize each reagent when it is recon
stituted.
Duplicate assays on an abnormal control
yielded a coefficient of variation of 3%.

REFERENCES
1.

-5-

Nygaard, S. F., and M. Rorth, Scand. J.
din. Lab. Invest., 24:399-403 (1969).

2.
3.

4.

5.
6.

•pO,NT<fo
IN
O. S. A-

Rose, Zelda B., and Judith Liebowitz,
Anal. Biochem., 35:177 (1970).
Benesch, R., and R. Benesch, Biochem.
biophys. Res. Common. 26:162-174
(1967).
Benesch, R., R. Benesch, and C. I. Yu,
Proc. natn. Acad. Sci. U. S. A., 59:526532 (1968).
Chanutin, A., and R. R. Curnish, Archs
Biochem. Biophys., 121:96-102 (1967).
Benesch, R ., and R. Benesch, Fedn. Proc.
Fedn. Am. Socs. exp. Bio!., 29:11011104 (1970).

c

7.
8.

9.
10.

11.

Idem, Nature, 221:618-622 (1969).
Bunn, H. F., and J. H. Jandl, New Engl.
J. Med., 282:1414-1420 (1970).
Snyder, M. L., and W. J. Reddy, Science,
N. Y., 169:879-880 (1970).
Torrance, J., P. Jacobs, A. Restrepo, J.
Eschbach, C. Lenfant, and C. A. Finch,
New Engl. J. Med., 283:165-169 (1970).
Eaton, J. W., and G. J. Brewer, Proc.
natn. Acad. Sci. U. S. A., 61:756-760
(1968).

CALBIOCHEM
10933 N. Torrey Pines Road
La Jolla, California 92037

